Citigroup’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-420,585
| Closed | -$589K | – | 5039 |
|
|
2023
Q3 | $589K | Buy |
420,585
+419,795
| +53,139% | +$588K | ﹤0.01% | 2299 |
|
|
2023
Q2 | $2.39K | Buy |
790
+285
| +56% | +$864 | ﹤0.01% | 4527 |
|
|
2023
Q1 | $3.16K | Sell |
505
-242
| -32% | -$1.51K | ﹤0.01% | 4322 |
|
|
2022
Q4 | $4.56K | Sell |
747
-206
| -22% | -$1.26K | ﹤0.01% | 4314 |
|
|
2022
Q3 | $11K | Sell |
953
-1,804
| -65% | -$20.8K | ﹤0.01% | 4233 |
|
|
2022
Q2 | $35K | Sell |
2,757
-2,106
| -43% | -$26.7K | ﹤0.01% | 4016 |
|
|
2022
Q1 | $55K | Sell |
4,863
-3,929
| -45% | -$44.4K | ﹤0.01% | 3988 |
|
|
2021
Q4 | $156K | Buy |
8,792
+4,994
| +131% | +$88.6K | ﹤0.01% | 3738 |
|
|
2021
Q3 | $87K | Buy |
3,798
+2,395
| +171% | +$54.9K | ﹤0.01% | 3724 |
|
|
2021
Q2 | $33K | Buy |
1,403
+408
| +41% | +$9.6K | ﹤0.01% | 4361 |
|
|
2021
Q1 | $31K | Sell |
995
-14,268
| -93% | -$445K | ﹤0.01% | 4334 |
|
|
2020
Q4 | $607K | Buy |
+15,263
| New | +$607K | ﹤0.01% | 2508 |
|